Betamethasone butyrate propionate/maxacalcitol

Drug Profile

Betamethasone butyrate propionate/maxacalcitol

Alternative Names: M 8010; M 801801; Marduox; Maxacalcitol/betamethasone butyrate propionate

Latest Information Update: 29 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chugai Pharmaceutical; Maruho
  • Developer Maruho
  • Class Analgesics; Anti-inflammatories; Antipruritics; Antipsoriatics; Calcium regulators; Dihydroxycholecalciferols; Fluorinated steroids; Glucocorticoids; Small molecules
  • Mechanism of Action Steroid receptor antagonists; Vitamin D3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Plaque psoriasis

Most Recent Events

  • 28 Mar 2016 Registered for Plaque psoriasis in Japan (Topical)
  • 25 May 2015 Preregistration for Plaque psoriasis in Japan (Topical)
  • 25 May 2015 Adverse events data from a phase III trial in Plaque psoriasis released by Chugai
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top